<DOC>
	<DOCNO>NCT02451657</DOCNO>
	<brief_summary>The aim study assess suitability select scale ( floor/ceiling effect , variability , test-retest reliability ) measure cognitive function child Down syndrome 6 month , evaluate influence covariates age , gender language neurocognitive scale .</brief_summary>
	<brief_title>Non-drug Study Evaluate Suitability Neurocognitive Tests Functioning Scales Measurement Cognitive Functioning Changes Children With Down Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>Males female age 6 11 diagnosis Down syndrome ( Trisomy 21 ) . Children may standard trisomy 21 , Robertsonian translocation , isochromosome 21 ( call 21q21q Robertsonian translocation ) , Down syndrome reciprocal translocation mosaicism . Down syndrome child meet clinical diagnostic criterion generalize anxiety disorder , autism spectrum disorder , attention deficit hyperactivity disorder , participate study provide consider clinically stable stable medication least 8 week prior baseline visit . Parent legal guardian/representative caregiver willing give write informed consent . Subjects sufficient vision hearing engage study evaluation refer parent . Mild hear loss allow . Children may able comply protocol perform outcome measure due significant hear visual impairment issue judge relevant investigator Significant sleep disruption moderate severe untreated obstructive sleep apnea . Any condition would make individual caregiver , opinion investigator , unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>